| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Oncolytics Biotech Inc. (ONCY) has 10 insiders with recent SEC Form 4 filings, including 12 buys and 0 sells. ONCY is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 567.0K | $510.3K | - | |
| Dir | 492.4K | $443.2K | - | |
| CFO | 287.5K | $258.8K | - | |
| Other | 282.8K | $254.5K | - | |
| VP | 115.1K | $103.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 12, 2026 | Kelly Jared | Chief Executive Officer | Buy | 5,050 | $0.96 | $4,848.00 | +4.6% | - | - | |
| Mar 11, 2026 | Parsons James T. | Director | Buy | 10,000 | $1.03 | $10,300.00 | +31.4% | - | - | |
| Feb 12, 2026 | Pisano Wayne | Director | Buy | 30,000 | $0.84 | $25,338.00 | +6.5% | - | - | |
| Feb 12, 2026 | Heineman Thomas Charles | Chief Medical Officer | Buy | 12,132 | $0.83 | $10,033.16 | +4.5% | - | - | |
| Feb 12, 2026 | Brown Deborah Margaret | Director | Buy | 25,000 | $0.85 | $21,240.00 | +29.5% | - | - | |
| Feb 12, 2026 | Hagerman Allison | VP, Product Development | Buy | 10,000 | $0.83 | $8,298.00 | +9.5% | - | - | |
| Feb 12, 2026 | Look Kirk | Chief Financial Officer | Buy | 12,000 | $0.84 | $10,104.00 | +4.4% | - | - | |
| Feb 12, 2026 | Andrews Patricia S | Director | Buy | 35,400 | $0.86 | $30,291.78 | +82.8% | - | - | |
| Feb 12, 2026 | Seizinger Bernd R.49 | Director | Buy | 100,000 | $0.83 | $83,454.00 | +10.1% | - | - | |
| Feb 12, 2026 | Kelly Jared | Chief Executive Officer | Buy | 35,100 | $0.84 | $29,520.60 | +22.9% | - | - |